Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-10 | Amended | $9,177,371 | $1,500,000 | Equity Only | 06b | SEC link |
| 2025-02-24 | Amended | $7,677,371 | $6,962,371 | Equity Only | 06b | SEC link |
| 2024-05-24 | New | $715,000 | $715,000 | Equity Only | 06b | SEC link |
| 2022-01-12 | Amended | $30,027,445 | $23,045,777 | Equity Only | 06b | SEC link |
| 2021-03-12 | New | $6,981,668 | $6,981,668 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| John J Baldwin | Director |
| Tao Du | Director |
| Jun Du | Director |
| Tom Tao Du | Director |
| Bin He | Director |
| Houman Hemmati | Director, Executive |
| Jingjie Li | Director |
| Bo Liang | Director, Executive |
| Xiaolu Sun | Director |
| Wei Wang | Director, Executive |
| Qi Zhu | Director |